AI is reinventing crime and cops aren't ready AI-powered crimes surge as law enforcement lags. Axios · Nov 14, 2025
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock Biogen, Inc. (NASDAQ: BIIB) and Eisai Co. Ltd. (OTC: ESALY) announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Benzinga · Sep 28, 2022